UBS has downgraded Indus Towers to “sell” from its earlier rating of “neutral” and cut its price target to ₹395 from ₹495 earlier. The revised price target implies a downside potential of 7% from current levels.
Barring Bluestone Jewellery, whose shares are trading with losses of over 5%, shares of Ajanta Pharma, Emcure Pharma, and Capital Small Finance Bank are trading with gains between 1% to 4% after their respective block deals on Tuesday.
The ED summons are not the only regulatory overhang on this IPO. The Competition Commission of India has an active inquiry into predatory pricing and anti-competitive discounting in quick commerce, with Zepto squarely named.
HSBC expects IDFC First Bank’s core pre-provision operating profit (PPOP) to grow at a compound annual growth rate (CAGR) of 35% between financial year 2026 and 2029, supported by strong loan growth and improving profitability metrics.
Markets remain unconvinced that the latest pause in hostilities will lead to a lasting peace. Iran and Israel have both signalled a halt to direct attacks following an appeal from US President Donald Trump. However, Tehran warned it could resume…
Edelweiss Financial Services NCD issue offers up to ₹300 crore, yields up to 10%, multiple tenures and BSE listing aim to attract income focused invest.
While company specific details are not available, the estimated relief for both Bharti Airtel and Vodafone Idea is said to be worth nearly ₹20,000 crore.
Gold and silver prices fall as strong US data lifts Treasury yields and rate hike fears, analysts eye key support levels and potential short term rebound.
Among the public shareholders, mutual funds of India had a 9.49% stake in NLC India, led mainly by Nippon Life India AMC (5.65%) and Kotak Mahindra MF (2.6%). The stock is up over 30% so far in 2026.
Over the last five trading sessions, the index has been locked in a range of 53,000 on the downside and 54,800 on the upside. The index tried testing 55,000 last Friday amidst a slew of measures announced by the government…